Despite the challenges that come with managing type 1 #diabetes, Marlaina has exemplified resilience with every step of her journey – including through her participation in a study for islet transplantation at @UChicagoMed. Learn more: https://t.co/Q0rMLQjinj $ELDN
Great article from @GMA highlighting a study at @UChicagoMed evaluating an #immunosuppression approach including our investigational therapy, tegoprubart, for the prevention of islet #transplant rejection in subjects with type 1 #diabetes. https://t.co/LTam1Sme5F @ABC $ELDN